<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02097602</url>
  </required_header>
  <id_info>
    <org_study_id>RePOS</org_study_id>
    <nct_id>NCT02097602</nct_id>
  </id_info>
  <brief_title>Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery</brief_title>
  <official_title>Can Reticulated Platelets Predict the Outcome After Noncardiac Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study designed to monitor the course of the fraction of reticulated
      platelets and the correlation thereof to major adverse cardiac and cerebrovascular events
      after noncardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reticulated platelets (RP) are newly formed, immature platelets which in contrast to mature
      platelets have high granule content and a residual amount of mRNA. An increased mean platelet
      volume (MPV) and the fraction of RP have been shown to be correlated to cardiovascular events
      like myocardial infarction or cardiovascular death. However, there are no trials so far
      investigating how surgery impacts the fraction of RP and how this fraction correlates with
      the outcome after noncardiac surgery.

      Patients with an age above 18 years undergoing high-risk or intermediate-risk noncardiac
      surgery are to be included. The fraction of RP is to be investigated in routinely acquired
      blood samples preoperatively, postoperatively in the recovery room, as well as 24-72 hours
      after anaesthesia and surgery.

      A primary common endpoint are major adverse cardiac and cerebrovascular events (MACCEs), as
      well as deep vein thrombosis and pulmonary embolism. MACCEs are defined according to Sabaté
      et al. as: cardiac death, cerebrovascular death, nonfatal cardiac arrest, acute myocardial
      infarction, congestive heart failure, new cardiac arrhythmia, angina or stroke. Secondary
      endpoints are lengths of hospital stay and intensive care stay as well as mortality after 3
      months. All participants are to be contacted by phone three months after discharge and their
      health situation is to be determined.

      1000 patients will be enrolled in a defined time frame of six months
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>major adverse cardiac and cerebrovascular events (MACCEs)</measure>
    <time_frame>during the hospital stay, an expected average of 2 weeks</time_frame>
    <description>MACCEs are defined according to Sabaté et al. as: cardiac death, cerebrovascular death, nonfatal cardiac arrest, acute myocardial infarction, congestive heart failure, new cardiac arrhythmia, angina or stroke. Pulmonary embolism and deep vein thrombosis are further primary endpoints.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>three months after discharge</time_frame>
    <description>mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital and intensive care-stay</measure>
    <time_frame>three months after discharge</time_frame>
    <description>length of hospital and intensive care-stay</description>
  </secondary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Cardiac Death</condition>
  <condition>Congestive Heart Failure</condition>
  <condition>Angina Pectoris</condition>
  <condition>Stroke</condition>
  <condition>Pulmonary Embolism</condition>
  <condition>Deep Vein Thrombosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        High-risk or intermediate-risk surgical patients older than 18 years undergoing noncardiac
        surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  high-risk or intermediate-risk surgical patients undergoing noncardiac surgery

          -  age ≥ 18 years

          -  written informed consent

        Exclusion Criteria:

          -  low-risk surgery

          -  age &lt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bettina Jungwirth, MD</last_name>
    <role>Study Director</role>
    <affiliation>Klinikum rechts der Isar Technische Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aida Anetsberger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum rechts der Isar Technische Universität München</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Nakamura T, Uchiyama S, Yamazaki M, Okubo K, Takakuwa Y, Iwata M. Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. Thromb Res. 2002 May 15;106(4-5):171-7.</citation>
    <PMID>12297121</PMID>
  </reference>
  <reference>
    <citation>Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost. 2009 Jan;101(1):151-6.</citation>
    <PMID>19132202</PMID>
  </reference>
  <reference>
    <citation>Cesari F, Marcucci R, Gori AM, Caporale R, Fanelli A, Casola G, Balzi D, Barchielli A, Valente S, Giglioli C, Gensini GF, Abbate R. Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 Study. Thromb Haemost. 2013 May;109(5):846-53. doi: 10.1160/TH12-09-0709. Epub 2013 Mar 14.</citation>
    <PMID>23494003</PMID>
  </reference>
  <reference>
    <citation>Sabaté S, Mases A, Guilera N, Canet J, Castillo J, Orrego C, Sabaté A, Fita G, Parramón F, Paniagua P, Rodríguez A, Sabaté M; ANESCARDIOCAT Group. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth. 2011 Dec;107(6):879-90. doi: 10.1093/bja/aer268. Epub 2011 Sep 2.</citation>
    <PMID>21890661</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2014</study_first_submitted>
  <study_first_submitted_qc>March 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2014</study_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reticulated platelets</keyword>
  <keyword>noncardiac surgery</keyword>
  <keyword>MACCEs</keyword>
  <keyword>major adverse cardiac and cerebrovascular events</keyword>
  <keyword>outcome</keyword>
  <keyword>High-risk or intermediate-risk noncardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Death</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

